Skip to main content
SpringerLink
Log in

Betarezeptorenblocker

  • Chapter
  • First Online:
Arzneiverordnungs-Report 2019

  • 2859 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Arzneimittelkommission der deutschen Ärzteschaft (2009) 23. Arterielle Hypertonie: Arzneiverordnungen, 22. Aufl. Medizinische Medien Informations GmbH, Neu-Isenburg, S 597–628

    Google Scholar 

  • Aursnes I, Osnes J-B, Tvede IF, Gasemyr J, Natvig B (2007) Does atenolol differ from other β-adrenergic blockers? Bmc Clin Pharmacol 7:4

    Article  Google Scholar 

  • Barron AJ, Zaman N, Cole GD, Wensel R, Okonko DO, Francis DP (2013) Sytematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: recommendations for patient information. Int J Cardiol 168:3572–3579

    Article  Google Scholar 

  • Beevers DG (2005) The end of beta blockers for uncomplicated hypertension? Lancet 366:1510–1512

    Article  Google Scholar 

  • Bowman AJ, Chen CP, Ford GA (1994) Nitric oxide mediated venodilator effects of nebivolol. Brit. J Clin Pharmacol 38:199–204

    Article  CAS  Google Scholar 

  • Chatterjee S, Biondi-Zoccai G, Abbate A, D’Ascenzo F, Castagno D, Van Tassell B, Mukherjee D, Lichstein E (2013) Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis. BMJ 346:f596

    Article  Google Scholar 

  • Chobanian AV et al (2003) Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute;Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7). JAMA 289:2560–2572 (Erratum in: JAMA 2003, 920:197)

    Article  CAS  Google Scholar 

  • CIBIS II Study (1999) The cardiac insufficiency bisoprolol study II (CIBIS II): a randomised trial. Lancet 353:9–13

    Article  Google Scholar 

  • Deutsche Gesellschaft für Kardiologie European Society of Cardiology Deutsche Gesellschaft für Kardiologie (2013) Leitlinien für das Management der arteriellen Hypertonie: www.escardio/org-guidelines, www.dgk.org, www.hochdruckliga.de. Eur Heart J 34:2159–2219. https://doi.org/10.1093/euroheartj/eht151

    Article  Google Scholar 

  • DiNicolantonio JJ, Fares H, Niazi AK, Chatterjee S, D’Ascenzo F, Cerrato E, Biondi-Zoccai G, Lavie CJ, Bell DS, O’Keefe JH (2015): β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature.Open Heart 2(1): e000230. doi: https://doi.org/10.1136/openhrt-2014-000230

  • Du Q, Sun Y, Ding N, Lu L, Chen Y (2014) Beta-blockers reduce the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies. PLoS ONE 26:e113048. https://doi.org/10.1371/journal.pone.0113048

    Article  CAS  Google Scholar 

  • Eschenhagen T, Erdmann E (2010) 16. Herzinsuffizienz. In: Lemmer B, Brune K (Hrsg) Pharmakotherapie – Klinische Pharmakologie, 14. Aufl. Springer, Heidelberg New York, S 229–243

    Chapter  Google Scholar 

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2017) GOLD 2017 Global Strategy for the Diagnosis, Management and Prevention of COPD. http://www.goldcopd.org

    Google Scholar 

  • Grundt C, Meier K, Grundt A, Lemmer B (2007) Evidence for an estradiol-agonistic action of nebivolol in spontaneously hypertensive rats. J Hypertens 25:1001–1007

    Article  CAS  Google Scholar 

  • Hines KL, Peebles RS (2017) Management of the asthma-COPD overlap syndrome (AOCS): a review of the evidence. Curr Allergy Asthma Rep 17:15. https://doi.org/10.1007/s11882-017-0683-4

    Article  PubMed  Google Scholar 

  • Hohlfeld T, Kelm M (2010) 17. Koronare Herzkrankheit. In: Lemmer B, Brune K (Hrsg) Pharmakotherapie – Klinische Pharmakologie, 14. Aufl. Springer, Heidelberg New York, S 245–257

    Chapter  Google Scholar 

  • Hoppe UC, Erdmann E (2010) Herzinsuffizienz Update 2010 und aktuelle ESC-Leitlinien. Herz 35:535–541

    Article  CAS  Google Scholar 

  • Kintscher U, Böhm M, Goss F, Kolloch R, Kreutz R, Schmieder R, Schunkert H (2014) Kommentar zur 2013-ESH/ESC-Leitlinie zum Management der arteriellen Hypertonie. Kardiologie 8:223–230

    Article  CAS  Google Scholar 

  • Kreutz R, Kolloch R (2010) Arterielle Hypertonie. In: Lemmer B, Brune K (Hrsg) Pharmakotherapie – Klinische Pharmakologie, 14. Aufl. Springer, Berlin Heidelberg New York, S 197–218

    Chapter  Google Scholar 

  • Léauté-Labrèze C, Hoeger P, Mazereew-Hautier J et al (2015) A randomized, controlled trial of propranolol in infantile hemangioma. N Eng J Med 19:735–746

    Article  Google Scholar 

  • Lindholm LH, Carlberg B, Samuelsson O (2005) Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 366:1545–1553

    Article  CAS  Google Scholar 

  • MERIT-HF Study (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure. Lancet 353:2001–2007

    Article  Google Scholar 

  • Moen MD, Wagstaff AJ (2006) Nebivolol – a review of its use in the management of hypertension and chronic heart failure. Drugs 66:1389–1409

    Article  CAS  Google Scholar 

  • National Institute for Health and Care Excellence (NICE) (2011) Hypertension – Clinical management of primary hypertension in adults. Issued: August 2011. NICE clinical guideline 127. guidance.nice.org.uk/cg127

    Google Scholar 

  • Nationale VersorgungsLeitlinie (2013) Chronische Herzinsuffizienz. http://www.leitlinien.de/nvl/herzinsuffizienz

    Google Scholar 

  • Packer M, Coats AJS, Fowler MB, Katus HA et al (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651–1658

    Article  CAS  Google Scholar 

  • POISE Study Group (2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial) a randomized controlled trial. Lancet 371:1839–1847

    Article  Google Scholar 

  • Sackner-Bernstein J (2005) Reducing the risks of sudden death and heart failure post myocardial infarction: utility of optimized pharmacotherapy. Clin Cardiol 28(11 Suppl 1):I19–27

    PubMed  Google Scholar 

  • Salpeter S, Ormiston T, Salpeter E, Wood-Baker R (2006) Cardioselective beta-blockers for reversible airway disease. Cochrane Libr Cochrane Collab 1:2006

    Google Scholar 

  • Tzemos N, Lim PO, MacDonald TM (2001) Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study. Circulation 104:511–514

    Article  CAS  Google Scholar 

  • Wiysonge CS, Bradley HA, Volmink J, Mayosi MB, Mbewu A, Opie LH (2012) Beta-blockers for hypertension. Cochrane Database Syst Rev Nov 14: CD002003

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmakologie und Toxikologie, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, Mannheim, Deutschland

    Prof. Dr. med. Dr. h.c. Björn Lemmer

Authors
  1. Prof. Dr. med. Dr. h.c. Björn Lemmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Björn Lemmer .

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut, Universität Heidelberg, Heidelberg, Baden-Württemberg, Germany

    Ulrich Schwabe

  2. Köln, Nordrhein-Westfalen, Germany

    Dieter Paffrath

  3. Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ), Berlin, Berlin, Germany

    Wolf-Dieter Ludwig

  4. Wissenschaftliches Institut der AOK, Berlin, Berlin, Germany

    Jürgen Klauber

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lemmer, B. (2019). Betarezeptorenblocker. In: Schwabe, U., Paffrath, D., Ludwig, WD., Klauber, J. (eds) Arzneiverordnungs-Report 2019. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-59046-1_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-59046-1_22

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-59045-4

  • Online ISBN: 978-3-662-59046-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation